Cost reduction and optimization of CHO mAb-producing perfusion cell culture by identifying viability-limiting media components
Conference Dates
October 20 - 24, 2024
Abstract
Please click Additional Files below to see the full abstract.
Recommended Citation
Milla Neffling, "Cost reduction and optimization of CHO mAb-producing perfusion cell culture by identifying viability-limiting media components" in "Integrated Continuous Biomanufacturing VI", Ana Azevedo, Instituto Superior Técnico, Portugal; Aaron Noyes, Apogee Therapeutics, USA; Kevin Brower, Sanofi, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/biomanufact_vi/43
57.pdf (82 kB)
COinS